Results 1 to 10 of about 298,741 (199)

Assessment of the Prevalence of Human Papillomavirus and Knowledge Among Patients at the Dermatology Clinic of Shahid Faghihi Hospital in Shiraz [PDF]

مجله علوم پزشکی صدرا
Introduction: The prevalence of human papillomavirus (HPV) infection is increasing worldwide. Limited studies have been conducted in Iran regarding knowledge about this virus. This study was designed to investigate the prevalence of HPV infection and the
Matin Ahmadpour, Maryam Hekmat, Negin Fazelzadeh Haghighi   +2 more
doaj   +1 more source

Vaccination Coverage for Medically Indicated Vaccines in a Convenience Sample of Severely Immunocompromised Patients with COVID-19: An Observational Cohort Study

Vaccines
Background: In recent decades, the number of immunocompromised patients (ICPs) has increased significantly. ICPs have an impaired immune system, making them susceptible to complicated infections.
Elsemieke te Linde, Marjolein P. M. Hensgens, Albert M. Vollaard, Annelies Verbon, Anke H. W. Bruns   +4 more
doaj   +1 more source

Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development

Virology Journal, 2010
We investigated the prevalence of human papillomavirus (HPV) infection and the distribution of high-risk HPV genotypes among 2,308 high-risk Korean women to predict how much the current prophylactic HPV vaccines might affect the prevention of cervical ...
Rhee Jee Eun, Shin Mi Yeong, Kim Choong Mo, Kee Hye Young, Chung Jae Keun, Min Sang-Kee, Kim Seong-Joon, Jang Dai-Ho, Kim Sung Soon, Choi Byeong-Sun   +9 more
doaj   +1 more source

Developing neoantigen cancer vaccines: where are we now?

Nature Communications
The success of immunotherapies such as immune checkpoint blockade and engineered T-cells has demonstrated the immune system’s anticancer potential. Although prophylactic vaccines against oncogenic viruses such as human papillomavirus prevent cancer by ...
Nune Markosyan, Robert H. Vonderheide
doaj   +1 more source

Efficacy of Human Papillomavirus Vaccines for Recalcitrant Anogenital and Oral Warts. [PDF]

J Clin Med, 2023
Ciccarese G, Herzum A, Serviddio G, Occella C, Parodi A, Drago F.   +5 more
europepmc   +1 more source

Application of human papillomavirus vaccines in the treatment of skin diseases

Pifu-xingbing zhenliaoxue zazhi
The human papillomavirus (HPV), which encompasses nearly 200 genotypes, is intimately associated with a wide range of skin diseases. HPV vaccines have been widely used to prevent diseases such as cervical cancer and condyloma acuminatum, and have also ...
ZHAO Yang, WAN Shifang, CAO Lu, FAN Jianyong   +3 more
doaj   +1 more source

Parents' Acceptance of COVID-19 Compared to Human Papillomavirus Vaccines. [PDF]

J Adolesc Health, 2022
Footman A, Kanney N, Niccolai LM, Zimet GD, Overton ET, Davies SL, Van Der Pol B.   +6 more
europepmc   +1 more source

Human Papillomavirus Vaccines. [PDF]

J Infect Dis, 2021
Markowitz LE, Schiller JT.
europepmc   +1 more source

Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines

Human Vaccines & Immunotherapeutics
Chikungunya virus (CHIKV), transmitted through Aedes mosquitoes, is a significant global health concern. Various vaccine platforms have been explored to combat CHIKV, including formalin inactivation, live-attenuated strains, virus-like particles (VLPs ...
Ariel Bardach, Martin Brizuela, Mabel Berrueta, Agustín Ciapponi, Juan M. Sambade, Jamile Ballivian, Vanesa Ortega, Noelia Castellana, Daniel Comandé, Edward P. K. Parker, Beate Kampmann, Katharina Stegelmann, Xu Xiong, Andy Stergachis, Flor M. Munoz, Pierre Buekens, Agustina Mazzoni   +16 more
doaj   +1 more source

Kikuchi-Fujimoto Disease: a rare type of lymphadenopathy and its plausible relationship with human papillomavirus vaccines. [PDF]

Rev Esp Quimioter, 2023
Rodríguez-Ferreras A, Maray I, Coya-Fernández C, Octavio-Bocigas MM, Fernández-Del Río MF, Casares-López S, Ruiz-Salazar J.   +6 more
europepmc   +1 more source